American Gastroenterological Association Institute Medical Position Statement on the Use of Gastrointestinal Medications in Pregnancy
This document presents the official recommendations of the American Gastroenterological Association (AGA) Institute on “Use of Gastrointestinal Medications in Pregnancy.” It was approved by the Clinical Practice and Economics Committee on February 22, 2006, and by the AGA Institute Governing Board on April 20, 2006.
The Medical Position Statements (MPS) developed under the aegis of the American Gastroenterological Association (AGA) Institute and its Clinical Practice and Economics Committee (CPEC) were approved by the AGA Institute Governing Board. The data used to formulate these recommendations are derived from the data available at the time of their creation and may be supplemented and updated as new information is assimilated. These recommendations are intended for adult patients, with the intent of suggesting preferred approaches to specific medical issues or problems. They are based upon the interpretation and assimilation of scientifically valid research, derived from a comprehensive review of published literature. Ideally, the intent is to provide evidence based upon prospective, randomized placebo-controlled trials; however, when this is not possible the use of experts’ consensus may occur. The recommendations are intended to apply to healthcare providers of all specialties. It is important to stress that these recommendations should not be construed as a standard of care. The AGA Institute stresses that the final decision regarding the care of the patient should be made by the physician with a focus on all aspects of the patient’s current medical situation.
PII: S0016-5085(06)00864-X
doi:10.1053/j.gastro.2006.04.048
© 2006 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights reserved.
